175 related articles for article (PubMed ID: 36062783)
21. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis.
Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X
Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856
[TBL] [Abstract][Full Text] [Related]
22. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
Jiang W; Guo MH; Hai X
World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
[TBL] [Abstract][Full Text] [Related]
23. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
24. Exercise Affects the Formation and Recovery of Alcoholic Liver Disease through the IL-6-p47
Cui W; Li X; Xue W; Wei H; Zhou G; Qiu Y; Cui D
Cells; 2022 Apr; 11(8):. PubMed ID: 35455983
[TBL] [Abstract][Full Text] [Related]
25. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
[TBL] [Abstract][Full Text] [Related]
26. [Study on the correlation between type 2 diabetes mellitus combined with non-alcoholic steatohepatitis and aerobic exercise performance].
Zhang J; Li L; Yu HY; Li Y; Wang FM; Di FS
Zhonghua Gan Zang Bing Za Zhi; 2023 Oct; 31(10):1068-1074. PubMed ID: 38016772
[No Abstract] [Full Text] [Related]
27. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats.
Yang QH; Hu SP; Zhang YP; Xie WN; Li N; Ji GY; Qiao NL; Lin XF; Chen TY; Liu HT
Chin J Integr Med; 2011 Mar; 17(3):205-11. PubMed ID: 21359922
[TBL] [Abstract][Full Text] [Related]
28. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.
Chen P; Li Y; Xiao L
Exp Ther Med; 2021 Oct; 22(4):1109. PubMed ID: 34504563
[TBL] [Abstract][Full Text] [Related]
29. Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression.
Zhang N; Qu Y; Qin B
Clin Exp Pharmacol Physiol; 2021 Aug; 48(8):1125-1136. PubMed ID: 33721354
[TBL] [Abstract][Full Text] [Related]
30. The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
Zhang M; Yuan Y; Wang Q; Li X; Men J; Lin M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30291215
[TBL] [Abstract][Full Text] [Related]
31. [Study of the effect of liraglutide on the correlation between NLRP3 inflammasome and non-alcoholic fatty liver disease].
Ma ZZ; Ao N; Yang N; Yang J; Jin S; Du C; Du J
Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):624-630. PubMed ID: 36038324
[No Abstract] [Full Text] [Related]
32. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
[TBL] [Abstract][Full Text] [Related]
34. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
Yu J; Yang X; Luo Y; Yang X; Yang M; Yang J; Zhou J; Gao F; He L; Xu J
PLoS One; 2017; 12(7):e0180218. PubMed ID: 28686624
[TBL] [Abstract][Full Text] [Related]
36. Carbenoxolone ameliorates hepatic lipid metabolism and inflammation in obese mice induced by high fat diet via regulating the JAK2/STAT3 signaling pathway.
Chen Y; Lu W; Jin Z; Yu J; Shi B
Int Immunopharmacol; 2019 Sep; 74():105498. PubMed ID: 31261036
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease (NAFLD) in rats.
Ghezelbash B; Shahrokhi N; Khaksari M; Ghaderi-Pakdel F; Asadikaram G
Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083445
[TBL] [Abstract][Full Text] [Related]
38. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
Wang W; Shi LP; Shi L; Xu L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
[No Abstract] [Full Text] [Related]
40. [Change in plasma nesfatin-1 concentration within high-fat diet induced nonalcoholic fatty liver disease rat models].
Wu R; Chen Z; Xu Y; Ge J; Lü X
Wei Sheng Yan Jiu; 2016 May; 45(3):452-7. PubMed ID: 27459811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
